Interferon-lambda as a potential therapeutic agent in cancer treatment

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Håkan C Steen, Ana M Gamero

Abstract

The discovery that type I interferon (IFN-alpha/beta) inhibited tumor cell growth was welcomed initially with great excitement as it rapidly became a U.S. Food and Drug Administration-approved drug to treat several forms of cancer. In time, this enthusiasm diminished as severe toxicity associated with IFN-alpha administration, resistance to the therapy, or less than optimal responses became evident in cancer patients, thus restricting its clinical use and reducing its potential as an anticancer drug. The recent discovery of a third type of IFN [IFN-lambda/interleukin (IL)-29/IL-28], which shares the same biological properties of type I IFNs, opens the door for evaluating the therapeutic potential of IFN-lambda as it uses a distinct receptor complex whose expression, unlike type I IFN receptors, is restricted to cells of specific lineage. It is unclear whether the mechanism by which type III IFNs restrict tumor cell proliferation is different or the same from the one utilized by type I IFN. Nevertheless, accumulating evidence as described in this review suggests that, in contrast to IFN-alpha therapy, IFN-lambda therapy could be less toxic and suitable for certain types of malignancies as not all cells are responsive to this cyt...Continue Reading

References

Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Dec 17, 2002·Nature Immunology·Sergei V KotenkoRaymond P Donnelly
May 27, 2003·Apoptosis : an International Journal on Programmed Cell Death·M Chawla-SarkarE C Borden
May 5, 2004·Journal of Leukocyte Biology·Raymond P DonnellyHarold Dickensheets
Jul 30, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Stephan BrandJulia Dambacher
May 3, 2006·Biochemical and Biophysical Research Communications·Kathrin ZitzmannChristoph J Auernhammer
Jun 6, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Atsuko SatoTakashi Murakami
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Sean E DoyleKevin M Klucher
Mar 16, 2007·Genes and Immunity·W J JordanG Gallagher
Apr 4, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Muneo NumasakiMutsuo Yamaya
May 16, 2007·The Journal of Biological Chemistry·Sidney Pestka
Jul 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John M KirkwoodHelen J Gogas
Nov 7, 2008·Genes and Immunity·C DellgrenR Hartmann
Dec 2, 2008·Cell Proliferation·W LiS V Kotenko
Mar 24, 2009·American Journal of Hematology·Carolina PavlovskyJorge E Cortes
Apr 30, 2009·Cancer·David F McDermott
May 15, 2009·Nature Reviews. Cancer·Tarek Abbas, Anindya Dutta
May 22, 2009·The Journal of Biological Chemistry·Hans Henrik GadRune Hartmann
Nov 3, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Quanhai LiMasatoshi Tagawa
Jan 16, 2010·Annals of the New York Academy of Sciences·Dennis M MillerDoug E Williams
Jan 28, 2010·Molecular Cancer Therapeutics·Kristan D GuenterbergWilliam E Carson

❮ Previous
Next ❯

Citations

Dec 21, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Otto Haller, Georg Kochs
Aug 18, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Raymond P Donnelly, Sergei V Kotenko
Apr 11, 2013·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Kevin P Kotredes, Ana M Gamero
Aug 20, 2015·The Journal of Investigative Dermatology·Adewonuola A AlaseMiriam Wittmann
Sep 29, 2015·Chinese Journal of Cancer·Jia-Li HuSong Gao
Apr 8, 2014·BioMed Research International·Valli De ReAnna Linda Zignego
Nov 16, 2012·Human Vaccines & Immunotherapeutics·Kevin ShahKenneth E Ugen
Sep 18, 2016·Critical Reviews in Oncology/hematology·Noah E KelmYujiang Fang
Jan 1, 2011·Cancers·Sylvia Lee, Kim Margolin
Feb 11, 2015·Journal of Innate Immunity·Andrew Stiff, William Carson
Oct 19, 2017·Cold Spring Harbor Perspectives in Biology·Xiaoting WangSascha Rutz
Mar 23, 2017·Frontiers in Immunology·Xu WangWen-Zhe Ho
Sep 30, 2016·Expert Opinion on Therapeutic Targets·Mohammed Eslam, Jacob George
Mar 15, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xing ZhangTomozumi Imamichi
Jun 26, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Salma B AbdelbakyIslam A Khalil

❮ Previous
Next ❯

Software Mentioned

BLAST

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in Immunology
Sergei V Kotenko
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Raymond P Donnelly, Sergei V Kotenko
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
Markus MordsteinPeter Staeheli
© 2021 Meta ULC. All rights reserved